期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 39, 期 12, 页码 1021-1032出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2018.10.004
关键词
-
资金
- Epstein Foundation
- NCI CCSG [P30CA030199, P30CA014195]
- NCI [P01CA120964, R35CA220538]
- NATIONAL CANCER INSTITUTE [R35CA220538, P01CA120964, P30CA030199, P30CA014195] Funding Source: NIH RePORTER
During times of stress, autophagy is a cellular process that enables cells to reclaim damaged components by a controlled recycling pathway. This mechanism for cellular catabolism is dysregulated in cancer, with evidence indicating that cancer cells rely on autophagy in the hypoxic and nutrient-poor microenvironment of solid tumors. Mounting evidence suggests that autophagy has a role in the resistance of tumors to standard-of-care (SOC) therapies. Therefore, there is significant interest in the discovery of small molecules that can safely modulate autophagy. In this review, we describe recent advances in the identification of new pharmacological compounds that modulate autophagy, with a focus on their mode of action, value as probe compounds, and validation as potential therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据